Status:
COMPLETED
The Safety of S53P4 Bioactive Glass for Mastoid Obliteration
Lead Sponsor:
Diakonessenhuis, Utrecht
Conditions:
Mastoid Cavity
Eligibility:
All Genders
Brief Summary
In recent years, mastoid obliteration (MO) after mastoidectomy has gained popularity. However, the choice for obliteration material has been a point of discussion. Autologous materials have the advant...
Eligibility Criteria
Inclusion
- Canal wall up or canal wall down mastoidectomy
- Operated between 2010 and 2022
- All indications are included
Exclusion
- Other surgical techniques, such as subtotal petrosectomy
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
1196 Patients enrolled
Trial Details
Trial ID
NCT06160388
Start Date
January 1 2023
End Date
March 1 2025
Last Update
July 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diakonessenhuis
Utrecht, Utrecht, Netherlands, 3582KE